Page 106 - ITPS-8-3
P. 106
INNOSC Theranostics and
Pharmacological Sciences Biomarkers for early heart risks in pre-eclampsia
17. Ahmed S, Jafri R. Point of care tests-the future of diagnostic 25. Fox R, Kitt J, Leeson P, Aye CYL, Lewandowski AJ.
medicine. EJIFCC. 2024;35(3):140-141. Preeclampsia: Risk factors, diagnosis, management, and
18. Eddy AC, Bidwell GL, George EM. Pro-angiogenic the cardiovascular impact on the offspring. J Clin Med.
therapeutics for preeclampsia. Biol Sex Differ. 2018;9:36. 2019;8(10):1625.
doi: 10.1186/s13293-018-0195-5 doi: 10.3390/jcm8101625
19. Tomkiewicz J, Darmochwał-Kolarz DA. Biomarkers for 26. Adedinsewo DA, Pollak AW, Phillips SD, et al. Cardiovascular
early prediction and management of preeclampsia: A disease screening in women: Leveraging artificial intelligence
comprehensive review. Med Sci Monit. 2024;30:e944104. and digital tools. Circ Res. 2022;130(4):673-690.
doi: 10.12659/MSM.944104 doi: 10.1161/CIRCRESAHA.121.319876
20. Verlohren S, Brennecke SP, Galindo A, et al. Clinical 27. Ng KW, Chaturvedi N, Coté GL, et al. Biomarkers and
interpretation and implementation of the sFlt-1/PlGF point of care screening approaches for the management of
ratio in the prediction, diagnosis and management of preeclampsia. Commun Med. 2024;4:208.
preeclampsia. Pregnancy Hypertens. 2022;27:42-50. doi: 10.1038/s43856-024-00642-4
doi: 10.1016/j.preghy.2021.12.003 28. Sufriyana H, Wu YW, Su EC. Artificial intelligence-assisted
21. Guan X, Fu Y, Liu Y, et al. The role of inflammatory prediction of preeclampsia: Development and external
biomarkers in the development and progression of pre- validation of a nationwide health insurance dataset of
eclampsia: A systematic review and meta-analysis. Front the BPJS Kesehatan in Indonesia. EBioMedicine. 2020;
Immunol. 2023;14:1156039. 54:102710.
doi: 10.3389/fimmu.2023.1156039 doi: 10.1016/j.ebiom.2020.102710
22. Afrose D, Chen H, Ranashinghe A, et al. The diagnostic 29. Ranjbar A, Montazeri F, Ghamsari SR, et al. Machine
potential of oxidative stress biomarkers for preeclampsia: learning models for predicting preeclampsia: A systematic
Systematic review and meta-analysis. Biol Sex Differ. review. BMC Pregnancy Childbirth. 2024;24:6.
2022;13:26. doi: 10.1186/s12884-023-06220-1
doi: 10.1186/s13293-022-00436-0 30. Melbourne A, Schabel MC, David AL, Roberts VHJ.
23. Mosquera-Heredia MI, Morales LC, Vidal OM, et al. Magnetic resonance imaging of placental intralobule
Exosomes: Potential disease biomarkers and new therapeutic structure and function in a preclinical nonhuman primate
targets. Biomedicines. 2021;9(8):1061. model. Biol Reprod. 2024;110(6):1065-1076.
doi: 10.3390/biomedicines9081061 doi: 10.1093/biolre/ioae035
24. Oladipo AF, Jayade M. Review of laboratory testing 31. Bhaltadak V, Ghewade B, Yelne S. A comprehensive review
and biomarker screening for preeclampsia. BioMed. on advancements in wearable technologies: Revolutionizing
2024;4(2):122-135. cardiovascular medicine. Cureus. 2024;16(5):e61312.
doi: 10.3390/biomed4020010 doi: 10.7759/cureus.61312
Volume 8 Issue 3 (2025) 100 doi: 10.36922/itps.7839

